US 2026/0000689 A1Published application

Targeting creb-heparan sulfate-fgf pathway for cancer treatment

AssigneeUniversity of South Florida

InventorsHua YANG, Lianchun WANG

Life of this patent

Estimating the term…

Abstract

The present disclosure provides for a method of treating a Pten-loss induced cancer in a subject in need thereof, the method comprising administering an inhibitor of a CREB-heparan sulfate-FGF axis.

Claims20

Dependent claims

A method of treating a Pten-loss induced cancer in a subject in need thereof, the method comprising administering an inhibitor of a CREB-heparan sulfate-FGF axis.

Dependencies are inferred from the claim text.

Facts

Application: 18/881,110Filed 6 Jul 2023
Priority: 6 Jul 2022
Published: 1 Jan 2026
Term ends: Not estimatedThe source records don’t support an estimate.

Classification20 codes

A61K 31/661
Phosphorus compounds: phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
A61K 31/716
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers,…:…
A61K 31/167
Having aromatic rings, e.g. colchicine, atenolol, progabide: having the nitrogen of a carboxamide group directly attached to the aromatic ring,…
A61K 31/337
Having oxygen as the only ring hetero atom, e.g. fungichromin: having four-membered rings, e.g. taxol

Family

Application63/367,782Us provisional application · filed 6 Jul 2022
US 2026/0000689 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results